
|Videos|May 20, 2015
What Lessons Have Been Learned from High Cost Hepatitis C Drugs?
Author(s)Davy James, Managing Editor
Marc O'Connor, Chief Operating Officer of Curant Health, discusses the main takeaways from the impact of hepatitis C drugs on specialty pharmacy.
Advertisement
Marc O'Connor, Chief Operating Officer of Curant Health, discusses the main takeaways from the impact of hepatitis C drugs on specialty pharmacy.
This video was recorded courtesy of Armada Health Care at the 2015 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
2
A Common Virus May Hold New Clues to Lupus
3
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
















































































































































































































